Aims. The aim of this study was to determine the prognostic significance of HER2 receptor expression in operable oesophagogastric adenocarcinoma. Methods. Eighty-five consecutive patients diagnosed with oesophagogastric adenocarcinoma [18 oesophageal (OC), 32 junctional (JC) and 35 gastric (GC)] undergoing potentially curative resection were studied retrospectively. Immunohistochemistry was used to determine HER2 status at endoscopic biopsy and resection specimen. The primary outcome measure was survival. Results. Twenty (24%) patients had HER2 positive tumours which was commoner in JC (14/32, 44% versus 2/18, 11% in OC and 4/35, 11% in GC
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...
Background: Gastric carcinoma is a deadly disease with high mortality. A better understanding of the...
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...
Aims. The aim of this study was to determine the prognostic significance of HER2 receptor expression...
Background: HER2 is an important biomarker in gastric and gastroesophageal junction tumors. Expressi...
AIM: To investigate human epidermal growth factor 2 (HER2) overexpression and validate its prognos...
Through the recent conduct of the ToGA trial, HER2 has shown to be predictive for the treatment with...
In this study, we investigated the rate of human epidermal growth factor receptor 2 (HER2) overexpre...
INTRODUCTION: Gastric cancer show varying clinical behaviour and response to chemotherapy, determi...
Human epidermal growth factor receptor 2 (HER2) dysregulation is associated with tumorigenesis in ga...
BACKGROUND: Gastric cancer is the one of the leading causes of cancer related death worldwide. Epid...
Introduction: HER2 overexpression is present in 7 to 34% of gastric carcinomas. Several studies have...
Background: HER2 (ERBB2 or HER2/neu) is a tyrosine-kinase increasing cell proliferation. Overexpress...
AIMS: Neoadjuvant treatment has now become the standard of care for oesophageal and gastric cancer. ...
[Background] A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA] study) esta...
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...
Background: Gastric carcinoma is a deadly disease with high mortality. A better understanding of the...
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...
Aims. The aim of this study was to determine the prognostic significance of HER2 receptor expression...
Background: HER2 is an important biomarker in gastric and gastroesophageal junction tumors. Expressi...
AIM: To investigate human epidermal growth factor 2 (HER2) overexpression and validate its prognos...
Through the recent conduct of the ToGA trial, HER2 has shown to be predictive for the treatment with...
In this study, we investigated the rate of human epidermal growth factor receptor 2 (HER2) overexpre...
INTRODUCTION: Gastric cancer show varying clinical behaviour and response to chemotherapy, determi...
Human epidermal growth factor receptor 2 (HER2) dysregulation is associated with tumorigenesis in ga...
BACKGROUND: Gastric cancer is the one of the leading causes of cancer related death worldwide. Epid...
Introduction: HER2 overexpression is present in 7 to 34% of gastric carcinomas. Several studies have...
Background: HER2 (ERBB2 or HER2/neu) is a tyrosine-kinase increasing cell proliferation. Overexpress...
AIMS: Neoadjuvant treatment has now become the standard of care for oesophageal and gastric cancer. ...
[Background] A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA] study) esta...
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...
Background: Gastric carcinoma is a deadly disease with high mortality. A better understanding of the...
This thesis examines factors influencing contemporary outcomes of patients managed by the South East...